Johnson & Johnson Stock Is STILL the Cure for a Volatile Market
Market volatility is back on the menu, and Johnson & Johnson stock (NYSE: JNJ) is still a perfect dividend growth play in this environment.
Read More
Author: Charles Sizemore
As Birth Rates Crash, AI Can Fill the Jobs Gap — That’s Just the Start!
Artificial intelligence (AI) will be key in filling roles as the birth rate declines. But entry-level positions are just the start.
The Fed Readies Its $1 Trillion Asset Eraser: 2 Keys for Your Portfolio
It’s been a nasty week in the market thanks to one entity: the Federal Reserve. Here’s how to trade the central bank’s hawkish plans.
Forget the Inverted Yield Curve! Buy This Recession-Proof REIT
It’s official. The dreaded yield curve inverted. Take any move in the bond market with a grain of salt, but here’s a REIT that is recession-proof should the economy turn that way.
Colleges Are Toast: How 16% Fewer Births Will Hammer Higher Education
Birth rates have been in decline for years, and that’s trouble for higher education. Let’s see what it means for investors or otherwise.
Watchlist
